RadNet (RDNT) Stock Analysis & Winston Score
RadNet runs a large network of outpatient imaging centers across the United States. These centers perform medical scans like MRIs, CT scans, X-rays, and mammograms for patients referred by doctors and hospitals. RadNet is one of the largest independent operators of freestanding imaging centers in the country. The company earns money by billing insurance companies, Medicare, Medicaid, and patients directly for each imaging procedure performed. RadNet operates primarily in California and several other states, with over 400 locations. Its scale gives it negotiating leverage with insurers and helps spread fixed costs across a large volume of scans. RadNet is also investing in AI-powered software tools designed to help radiologists read scans faster and more accurately, which could become a meaningful revenue stream — but the business currently runs on thin margins, meaning any rise in labor costs or reimbursement rate cuts from insurers could quickly pressure profitability.
Winston Score: 27/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Weak (6/30)
- Growth: Mixed (7/20)
- Cash Flow: Weak (0/10)
- Stability: Mixed (3/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $76.82
Market Cap: $6.0B
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Exchange: NASDAQ
